CD8A and neoplasm: Combined with secretion of inhibitory cytokines, chemokines and depleting essential nutrient required for CD8 T cell activation, TAMs achieve subversion of host immune response via interference of CD8 T cell trafficking to the tumor site, and activation of T cell checkpoint blockade by upregulating inhibitory ligands such as PD-L1.